Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

19.14USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$19.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
194,906
52-wk High
$33.20
52-wk Low
$10.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 5.92 -0.447
Mar '17 6.22 -0.364
FY 2016 Dec '16 5.63 -0.305
Sep '16 4.87 -0.218
Jun '16 4.21 -0.361
Mar '16 1.78 -0.191
FY 2015 Dec '15 1.69 -0.149
Sep '15 1.69 -0.086
Jun '15 1.38 -0.087
Mar '15 1.29 -0.031
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 8.56 15.40 6.10 6.76
Quarter Ending Mar-18 2 6.25 7.50 5.00 --
Year Ending Dec-17 6 27.24 34.80 22.00 21.78
Year Ending Dec-18 6 35.91 54.00 23.70 32.85
Earnings (per share)
Quarter Ending Dec-17 5 -0.44 -0.28 -0.50 -0.30
Quarter Ending Mar-18 2 -0.54 -0.52 -0.55 --
Year Ending Dec-17 6 -1.67 -1.53 -1.75 -1.20
Year Ending Dec-18 6 -1.99 -1.52 -2.64 -1.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 49.36 100.67 5.40
Price to Book (MRQ) 5.95 13.50 5.38
Price to Tangible Book (MRQ) 5.95 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 47.11 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 40.68 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 141.65 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.76 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -69.49 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 9.33 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -200.83 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -209.85 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -204.48 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -204.48 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 217,577 25,314,503 864,673,366
Net Income/Employee (TTM) -444,894 3,332,048 101,717,513
Receivable Turnover (TTM) 12.02 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.08 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -16.08 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -17.54 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -22.51 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 172.65 -- --
EPS (TTM) % -303.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellia Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 41.99%
# of Holders: 135
Total Shares Held: 17,777,273
3 Mo. Net Change: 758,261
# New Positions: 20
# Closed Positions: 18
# Increased Positions: 66
# Reduced Positions: 45
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.